TheraKine was founded in 2004 with the goal of combining modern drugs and cutting edge technologies to prevent vision loss and reduce the occurrence of blindness in both humans and animals. TheraKine's team consists of a group of experts in a variety of fields, including biologic therapies, product and business development for ophthalmics and supported by international leaders in ophthalmology.
The TheraKine Team:
Founder:
SCOTT HAMPTON, CEO
A biotechnology engineer and commercialization expert with extensive experience in negotiating licensing agreements. Scott holds numerous patents for ophthalmic implants and surgical tools.
Medical Advisors:
ANDREAS REIFF, MD
Professor of Pediatrics and international expert in biologic drugs for autoimmune diseases. Dr. Reiff has established himself as a pioneer of biologic therapy for inflammatory eye diseases, gives lectures worldwide, and advises many of the world’s leading pharmaceutical companies.
GARY N. HOLLAND, MD
Vernon O. Underwood Family Professor of Ophthalmology, Cornea and Uveitis Division at the David Geffen School of Medicine at UCLA
IAONNIS PALLIKARIS, MD
Originally the co-inventor of LASIK eye surgery, Iaonnis is currently the Rector of the University of Crete Medical University.
C. STEPHEN FOSTER, MD, FACS
Professor of Ophthalmology, Harvard Medical School; Founder and President of the Massachusetts Eye Research and Surgery Institute (MERSI).
JAMES T. ROSENBAUM, MD
Professor of Medicine and Head of the Uveitis Clinic and Director of Inflammation Research at the Casey Eye Institute, Oregon Health and Science University
Dr. JOHN MARSHALL
Professor of Ophthalmology and Visual Science at King’s College, University of London
Management Advisors:
Dr. RAY CHOW
Founder of Bio-Mondo Consulting. Previously, Ray was the Executive Director of Global Marketing for Amgen, Inc.
JERRY SEELIG
Expert in Early Phase Business Development Alliance Building and Fundraising.
PHILIP M. BUSCEMI, OD
Head of Marketing for TheraKine, Phil has both built and served as an advisor to many leading ophthalmology companies.
Dr. MICHAEL D. AMOS
Biosciences Advisor to the Director of the Chemical Science and Technology Laboratory, National Institute of Standards and Technology (NIST), and founder of two biotechnology companies.